SEC Comment Letter for GSK (GSK) — Oct 15, 2012
GSK plc
Date: Oct. 15, 2012 · CIK: 0001131399 · Accession: 0000000000-12-056849
AI Filing Summary & Sentiment
File numbers found in text: 001-15170
Show Raw Text
Octo ber 1 5, 2012
Via E -mail
Mr. Simon Dingemans
Chief Financial Officer
GlaxoSmithKline plc
980 Great West Road
Brentford, TW8 9GS
England
Re: GlaxoSmithKline plc
Form 20 -F for the Fiscal Year Ended December 31, 2011
Filed March 13, 2012
File No. 001-15170
Dear Mr. Dingemans :
We have comple ted our review of your filing . We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the Un ited States. We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/ Gus Rodriguez
Gus Rodriguez
Accounting Branch Chief